Malignant News and Research

RSS

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

Combination therapy found to be effective against treatment-resistant hepatocellular carcinoma

A combination cancer therapy that is effective against treatment-resistant hepatocellular carcinoma (HCC) by inhibiting tumor growth and increasing survival has been identified by researchers at Massachusetts General Hospital.

30 Nov 2020

Study describes the role of Zmat3 in lymphoma and lung cancer development

A new study from the UPF and WEHI (the Walter and Eliza Hall Institute of Medical Research) in Melbourne, Australia, has described the role of p53 target gene Zmat3 in lymphoma and lung cancer development.

30 Nov 2020

Scientists use 3D mapping techniques to unravel mystery of blood stem cells

Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughout our life by looking at vast, uncharted regions of our genetic material that hold important clues to subtle biological changes in these cells.

25 Nov 2020

Cleveland Clinic team successfully used latest ablation technology to destroy large liver tumors

Cleveland Clinic is the first hospital in the world to use a recently FDA-approved ablation technology that can destroy large liver tumors.

24 Nov 2020

Researchers report a case of S-ICD implantation in patient with ccTGA and DDD pacemaker

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, Beijing, China consider implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition of the great arteries.

20 Nov 2020

Immune mechanism responsible for adverse inflammatory reactions after stem cell transplant identified

In the treatment of leukemia, stem cell transplantation subsequent to chemotherapy and radiation can often engender severe adverse inflammatory reactions - especially in the skin or in the gut, since these so-called barrier organs are more frequently affected.

19 Nov 2020

UV light induces new types of DNA damage that may cause malignant melanoma

Studies conducted in yeast show that exposure to ultraviolet light (UV) induces new types of DNA damage that may cause the deadliest form of skin cancer, malignant melanoma.

17 Nov 2020

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

Synthetic protein nanoparticle may treat aggressive brain cancer

A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

11 Nov 2020

$4 million NIH grant supports research for tackling teenage depression

According to the National Institute of Mental Health (NIMH), in 2017 approximately 13% of adolescents in the United States, or 3.2 million children aged 12 to 17, had at least one major episode of depression.

11 Nov 2020

Compound found in brown seaweeds could help treat malignant brain tumour

A compound found in brown seaweeds could help to treat one of the most common and aggressive forms of malignant brain tumour.

10 Nov 2020

Novel 3D-printed scaffold loaded with chemotherapy drug could reduce breast cancer recurrence

The recurrence of cancer after surgery is a major concern for patients. New findings from a QUT study have shown the potential for a novel 3D-printed porous scaffold which is loaded with a common chemotherapy drug that can reduce breast cancer recurrence in an experimental setting.

10 Nov 2020

Researchers propose a non-invasive, accurate method for melanoma detection

A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma.

10 Nov 2020

Melatonin may be a viable treatment option for COVID-19, study suggests

Results from a new Cleveland Clinic-led study suggest that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as an over-the-counter sleep aid, may be a viable treatment option for COVID-19.

9 Nov 2020

SARS-CoV-2 viral antigens found in non-pulmonary tissues in recovering patients

A team of researchers in Singapore, led by Dr. Joe Yeong, and Prof. Tony Kiat Hon Lim, have reported the presence of residual SARS-CoV-2 ribonucleic acid (RNA) – the virus' genetic material – in stool samples and gastrointestinal tissues from patients recovering from the coronavirus disease 2019 (COVID-19).

8 Nov 2020

Malignant News and Research

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Combination therapy found to be effective against treatment-resistant hepatocellular carcinoma

Study describes the role of Zmat3 in lymphoma and lung cancer development

Scientists use 3D mapping techniques to unravel mystery of blood stem cells

Cleveland Clinic team successfully used latest ablation technology to destroy large liver tumors

Researchers report a case of S-ICD implantation in patient with ccTGA and DDD pacemaker

Immune mechanism responsible for adverse inflammatory reactions after stem cell transplant identified

UV light induces new types of DNA damage that may cause malignant melanoma

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Synthetic protein nanoparticle may treat aggressive brain cancer

$4 million NIH grant supports research for tackling teenage depression

Compound found in brown seaweeds could help treat malignant brain tumour

Novel 3D-printed scaffold loaded with chemotherapy drug could reduce breast cancer recurrence

Researchers propose a non-invasive, accurate method for melanoma detection

Melatonin may be a viable treatment option for COVID-19, study suggests

SARS-CoV-2 viral antigens found in non-pulmonary tissues in recovering patients

Commonly prescribed anti-depressant may halt the growth of childhood sarcoma

Study reveals new mechanism underlying immune-cell activation

Experts release new guidance for endoscopists on how to assess colorectal lesions

Immunotherapy side effect could signal improved control of kidney cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News